Beijing has launched its AI+Healthcare Action Plan, covering the years 2025 to 2027, with a focused intent to integrate artificial intelligence into the pharmaceutical sector. This initiative aims to enhance the delivery of customized medical services and improve operational efficiency within the healthcare framework.

By leveraging AI technologies, the plan seeks to optimize drug development processes and tailor implant solutions to patient-specific needs. This move is expected to revolutionize patient care in the realm of pharmaceuticals and positions Beijing at the forefront of healthcare innovation.